Resources

The AMA has collected more than 400 educational and other resources to provide evidence-based recommendations for physicians and policymakers.

Total dispensed prescriptions to treat opioid use disorder (2012-2021)

From 2012 to 2021, medications to treat opioid use disorder (MOUD) increased 104%; from 2020 to 2021, however, it only increased 1.6%.

Total dispensed prescriptions for naloxone in retail pharmacies (2012-2021)

From 2016 to 2021, naloxone prescriptions dispensed from pharmacies increased from almost 134,000 to nearly 1.2 million prescriptions.

Opioid prescriptions by state (2012-2021)

From 2012 to 2021, every state in the nation saw a large decrease of prescription opioids dispensed from retail pharmacies.

Prescription drug monitoring program national survey (2022)

Physicians and other authorized users queried state prescription drug monitoring programs (PDMPs) more than 1.1 billion times in 2021

Issue brief: Nation’s drug-related overdose and death epidemic continues to worsen

This issue brief provides a one-page overview of the epidemic and select AMA advocacy initiatives and resources.

Words Matter

A guide from the Rhode Island Executive Office of Health and Human Services, Department of Behavioral Health Care, Developmental Disabilities and Healthcare, and Department of Health.

Safe and Effective Alleviation of Pain and Optimal Opioid Stewardship Information Statement

The CO’s CURE Initiative

Colorado’s Opioid Solution: Clinicians United to Resolve the Epidemic In 2019, Colorado Hospital Association, Colorado Medical Society and Colorado Consortium for Prescription Drug Abuse Prevention launched a new initiative designed to address the opioid epidemic – Colorado’s Opioid Solution: Clinicians United to Resolve the Epidemic (CO’s CURE). CO’s CURE brought together diverse clinical specialties, all committed to resolving the opioid epidemic in Colorado through the development of opioid prescribing guidelines that seek to treat patients’ pain more effectively while reducing unnecessary exposure to opioids.

Maine Drug Data Hub

The Maine Drug Data Hub is a collaboration between several state departments, the Governor’s Office and the University of Maine. The aggregation of state and community information on the hub provides resources, data, and visualizations to inform Mainers about efforts to reduce the harm caused by drug use and drug overdose and to track progress towards reaching the goals outlined in Governor Janet Mills’ Maine Opioid Response Strategic Action Plan. The data, information, and resources available on the Maine Drug Data Hub is constantly being updated. Data sets, reports, and graphics are updated monthly, quarterly, and annually. New data metrics are added as they become available.

OPTIONS – Overdose Prevention Through Intensive Outreach Naloxone and Safety

WITH SUBSTANCE USE DISORDER There are Multiple Pathways to Recovery From the grassroots to the Governor’s office, Maine is coming together for those affected by the opioid epidemic. We are on a mission to save lives and strengthen communities, and we’re putting all the options on the table. Because if we want to give people a fighting chance, we need to keep them alive, safe, and supported throughout their journey of active use and recovery.

Maine Board of Licensure in Medicine: Prescribing Resources

Prescribing controlled medications is challenging and complex. Many licensees may encounter patients who pose a risk of misuse or addiction to these medications. The links and documents on this page are intended to assist licensees who prescribe controlled medications by referencing resources and information that can be use in their practice.

State of Maine Opioid Response

Maine Opioid Response: 2021 Strategic Action Plan Opioid Response Seminar Series

AMA Substance Use and Pain Care Task Force

The AMA Substance Use and Pain Care Task Force urges physicians and other health care professions to continue taking action to help reverse the nation’s drug overdose epidemic—and the Task Force also calls on policymakers to take specific steps to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.

Learn More

Be part of the solution.

Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.